MedElevator Войти в исследования
← Поиск публикаций
Медицинская библиотека · Journal of addiction psychiatry · 2023

Are We Getting High Cause the Thrill is Gone?

Blum Kenneth, Mclaughlin Thomas, Gold Mark S, Gondre-Lewis Marjorie C, Thanos Panayotis K, Elman Igor, Baron David, Bowirrat Abdalla, Barh Debamyla, Khalsa Jag, Hanna Colin, Jafari Nicole, Zeine Foojan, Braverman Eric R, Dennen Catherine, Makale Milan T, Makale Miles, Sunder Keerthy, Murphy Kevin T, Badgaiyan Rajendra D

СтатьяПеревод в очереди

Аннотация

In the USA alone, opioid use disorder (OUD) affects approximately 27 million people. While the number of prescriptions may be declining due to increased CDC guidance and prescriber education, fatalities due to fentanyl-laced street heroin are still rising. Our laboratory has extended the overall concept of both substance and non-substance addictive behaviors, calling it "Reward Deficiency Syndrome (RDS)." Who are its victims, and how do we get this unwanted disorder? Is RDS caused by genes (Nature), environment (Neuro-epigenetics, Nurture), or both? Recent research identifies resting-state functional connectivity in the brain reward circuitry as a crucial factor. Analogously, it is of importance to acknowledge that the cumulative discharge of dopamine, governed by the nucleus accumbens (NAc) and modulated by an array of additional neurotransmitters, constitutes a cornerstone of an individual's overall well-being. Neuroimaging reveals that high-risk individuals exhibit a blunted response to stimuli, potentially due to DNA polymorphisms or epigenetic alterations. This discovery has given rise to the idea of a diminished 'thrill,' though we must consider whether this 'thrill' may have been absent from birth due to high-risk genetic predispositions for addiction. This article reviews this issue and suggests the general concept of the importance of "induction of dopamine homeostasis." We suggest coupling a validated genetic assessment (e.g., GARS) with pro-dopamine regulation (KB220) as one possible frontline modality in place of prescribing potent addictive opioids for OUD except for short time harm reduction. Could gene editing offer a 'cure' for this undesirable genetic modification at birth, influenced by the environment and carried over generations, leading to impaired dopamine and other neurotransmitter imbalances, as seen in RDS? Through dedicated global scientific exploration, we hope for a future where individuals are liberated from pain and disease, achieving an optimal state of well-being akin to the proverbial 'Garden of Eden'.

Для цитирования: Blum Kenneth, Mclaughlin Thomas, Gold Mark S, Gondre-Lewis Marjorie C, Thanos Panayotis K, Elman Igor, Baron David, Bowirrat Abdalla, Barh Debamyla, Khalsa Jag, Hanna Colin, Jafari Nicole, Zeine Foojan, Braverman Eric R, Dennen Catherine, Makale Milan T, Makale Miles, Sunder Keerthy, Murphy Kevin T, Badgaiyan Rajendra D. Are We Getting High Cause the Thrill is Gone?. Journal of addiction psychiatry. 2023.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.